GEP20115332B - Herbal composition for inflammatory disorders - Google Patents
Herbal composition for inflammatory disordersInfo
- Publication number
- GEP20115332B GEP20115332B GEAP200610647A GEAP2006010647A GEP20115332B GE P20115332 B GEP20115332 B GE P20115332B GE AP200610647 A GEAP200610647 A GE AP200610647A GE AP2006010647 A GEAP2006010647 A GE AP2006010647A GE P20115332 B GEP20115332 B GE P20115332B
- Authority
- GE
- Georgia
- Prior art keywords
- herbal composition
- inflammatory disorders
- composition
- flowering
- concerns
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 241000196324 Embryophyta Species 0.000 abstract 1
- 244000085223 Sphaeranthus indicus Species 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1226MU2005 | 2005-09-30 | ||
| US73644305P | 2005-11-14 | 2005-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20115332B true GEP20115332B (en) | 2011-11-25 |
Family
ID=37900158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP200610647A GEP20115332B (en) | 2005-09-30 | 2006-09-28 | Herbal composition for inflammatory disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7635494B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1931366B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5331962B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006296197B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2624049C (cg-RX-API-DMAC7.html) |
| EA (1) | EA014070B1 (cg-RX-API-DMAC7.html) |
| GE (1) | GEP20115332B (cg-RX-API-DMAC7.html) |
| MA (1) | MA29890B1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1931366T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007036900A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8981131B2 (en) * | 2007-07-27 | 2015-03-17 | Piramal Enterprises Limited | Tricyclic compounds for the treatment of inflammatory disorders |
| WO2009084032A2 (en) * | 2007-12-03 | 2009-07-09 | Vedic Elements Private Limited | Stable hydrophobic topical herbal formulation |
| WO2012014216A1 (en) * | 2010-07-28 | 2012-02-02 | Laila Nutraceuticals | 7-hydroxyfrullanolide and its analogs for prevention, control and treatment of metabolic disorders |
| US10105347B2 (en) | 2009-02-02 | 2018-10-23 | Laila Nutraceuticals | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels |
| CN102292093B (zh) * | 2009-02-02 | 2015-01-28 | 莱拉营养食品有限公司 | 用于代谢综合症控制的选自绒毛戴星草和莽吉柿的混合物 |
| WO2011033524A2 (en) * | 2009-08-04 | 2011-03-24 | Laila Nutraceuticals | Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases |
| WO2011083397A1 (en) * | 2010-01-05 | 2011-07-14 | Himalaya Global Holdings Limited | Herbal composition for skin disorders |
| PH12013500451A1 (en) * | 2010-09-11 | 2013-05-20 | Laila Nutraceuticals | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels |
| US8263579B2 (en) * | 2011-01-24 | 2012-09-11 | Piramal Healthcare Limited | Anti-inflammatory compounds |
| TW201427677A (zh) * | 2012-10-23 | 2014-07-16 | Piramal Entpr Ltd | 用於預防及治療腫瘤壞死因子-α媒介疾病中藥組合物 |
| EP3313384A4 (en) | 2015-06-23 | 2019-04-03 | Nobilis Therapeutics, Inc. | THERAPEUTIC IMMUNE MODULATION USING NOBLE GAS COMPOSITIONS |
| WO2017203540A1 (en) * | 2016-05-21 | 2017-11-30 | Laila Impex | Dietary supplements and compositions for enhancing physical performance and energy levels |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646687A (en) * | 1994-12-29 | 1997-07-08 | Lucent Technologies Inc. | Temporally-pipelined predictive encoder/decoder circuit and method |
| US6204523B1 (en) * | 1998-11-06 | 2001-03-20 | Lumileds Lighting, U.S., Llc | High stability optical encapsulation and packaging for light-emitting diodes in the green, blue, and near UV range |
| US6686676B2 (en) * | 2001-04-30 | 2004-02-03 | General Electric Company | UV reflectors and UV-based light sources having reduced UV radiation leakage incorporating the same |
| US6989412B2 (en) * | 2001-06-06 | 2006-01-24 | Henkel Corporation | Epoxy molding compounds containing phosphor and process for preparing such compositions |
| US6841647B2 (en) * | 2001-11-06 | 2005-01-11 | National Starch And Chemical Investment Holding Corporation | Fluid resistant silicone encapsulant |
| US7160972B2 (en) * | 2003-02-19 | 2007-01-09 | Nusil Technology Llc | Optically clear high temperature resistant silicone polymers of high refractive index |
| US7261441B2 (en) * | 2004-02-27 | 2007-08-28 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | LED device and method for directing LED light |
| WO2006016228A2 (en) * | 2004-08-02 | 2006-02-16 | Prashanth Kumar V | Cytotoxic peptide alkaloid and pharmaceutical compositions for the treatment of neoplastic diseases |
| US7229934B2 (en) * | 2004-10-18 | 2007-06-12 | International Business Machines Corporation | Porous organosilicates with improved mechanical properties |
-
2006
- 2006-09-28 AU AU2006296197A patent/AU2006296197B2/en not_active Ceased
- 2006-09-28 PL PL06809434T patent/PL1931366T3/pl unknown
- 2006-09-28 WO PCT/IB2006/053540 patent/WO2007036900A2/en not_active Ceased
- 2006-09-28 CA CA2624049A patent/CA2624049C/en active Active
- 2006-09-28 GE GEAP200610647A patent/GEP20115332B/en unknown
- 2006-09-28 EA EA200800850A patent/EA014070B1/ru active IP Right Revival
- 2006-09-28 JP JP2008532961A patent/JP5331962B2/ja not_active Expired - Fee Related
- 2006-09-28 EP EP06809434.1A patent/EP1931366B1/en active Active
-
2008
- 2008-03-28 US US12/079,853 patent/US7635494B2/en active Active
- 2008-04-29 MA MA30886A patent/MA29890B1/fr unknown
-
2009
- 2009-07-09 US US12/500,057 patent/US8206756B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2624049A1 (en) | 2007-04-05 |
| WO2007036900A2 (en) | 2007-04-05 |
| HK1112418A1 (en) | 2008-09-05 |
| CA2624049C (en) | 2016-01-12 |
| AU2006296197A2 (en) | 2008-06-05 |
| MA29890B1 (fr) | 2008-10-03 |
| AU2006296197A1 (en) | 2007-04-05 |
| US7635494B2 (en) | 2009-12-22 |
| US20090269427A1 (en) | 2009-10-29 |
| JP5331962B2 (ja) | 2013-10-30 |
| JP2009510051A (ja) | 2009-03-12 |
| EA200800850A1 (ru) | 2008-10-30 |
| US20080254157A1 (en) | 2008-10-16 |
| AU2006296197B2 (en) | 2012-08-09 |
| PL1931366T3 (pl) | 2013-11-29 |
| US8206756B2 (en) | 2012-06-26 |
| WO2007036900A3 (en) | 2007-08-02 |
| EP1931366B1 (en) | 2013-05-29 |
| EA014070B1 (ru) | 2010-08-30 |
| EP1931366A2 (en) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006003388A8 (en) | Compositions and methods for treating inflammatory disorders | |
| WO2007109804A3 (en) | Extracts and methods comprising cinnamon species | |
| WO2004078116A3 (en) | P38 inhibitors and methods of use thereof | |
| WO2007109801A3 (en) | Extracts and methods comprising ganoderma species | |
| WO2007109802A3 (en) | Extracts and methods comprising green tea species | |
| TW200510416A (en) | P38 inhibitors and methods of use thereof | |
| MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
| PH12013500356A1 (en) | Engineered anti-tslp antibody | |
| TW200628159A (en) | IL-12 modulatory compounds | |
| UA101493C2 (ru) | Производные азетидина и циклобутана как ингибиторы jak | |
| WO2009032888A3 (en) | Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract | |
| WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
| TN2011000466A1 (en) | Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof | |
| WO2008061109A3 (en) | Indazole derivatives useful as melanin concentrating receptor ligands | |
| MX337933B (es) | Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal. | |
| WO2010013254A3 (en) | Withania somnifera plant extract and method of preparation thereof | |
| MX2012004548A (es) | Nuevas composiciones para prevenir y/o tratar transtornos degenerativos del sistema nervioso central. | |
| ZA201003221B (en) | Tea composition and process for the manufacture thereof | |
| TW200720256A (en) | IL-12 modulatory compounds | |
| WO2008140641A3 (en) | Pure paliperidone and processes for preparing thereof | |
| WO2008104590A3 (en) | Novel dosage form | |
| MX2007002525A (es) | Compuestos de difeniletileno y usos de los mismos. | |
| WO2005073152A3 (de) | Verfahren zur herstellung von polyisobutenylphenolen | |
| WO2006078699A3 (en) | Oral care compositions derived from the labiatae family | |
| WO2005112965A3 (en) | Botanical anti-inflammatory compositions and methods |